Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasma electrolyte concentration refers to the measured amount of key charged minerals—primarily sodium, potassium, chloride, bicarbonate/carbon dioxide content—as well as calcium and magnesium present in blood plasma. These measurements are critical indicators of hydration status; acid-base equilibrium; kidney function; cardiac rhythm stability; neuromuscular activity; and overall metabolic health. The values are typically obtained through laboratory tests such as an “electrolyte panel” or “serum chemistry,” which guide diagnosis and management across numerous medical conditions including dehydration states, kidney dysfunctions, heart failure exacerbations, endocrine disorders like adrenal insufficiency/excesses—and more. Importantly—plasma electrolyte concentration is not itself a druggable target but reflects underlying physiological processes regulated by various proteins such as ion channels/pumps/transporters within organ systems like kidneys. In summary: "Plasma electrolyte concentration" describes a set of clinical measurements—not an individual molecular entity—and should not be considered a canonical therapeutic target. It serves instead as an essential biomarker for patient assessment across diverse medical contexts.
Not applicable for this entry. Drugs that affect plasma electrolytes do so by altering renal excretion/reabsorption or shifting ions between compartments. Examples: Diuretics increase urinary loss of sodium/potassium. ACE inhibitors reduce aldosterone-mediated sodium retention. Potassium binders remove excess potassium via the gut. These mechanisms act on organs/systems rather than on "plasma electrolyte concentration" itself.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasma electrolyte concentration.